Balanced Rock Investment Advisors’s Gilead Sciences GILD Stock Holding History

Balanced Rock Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Buy	4,990 +31	+0.6%	+$4.08K	0.39%	52
2026 Q1	$691K	Sell	4,959 -60	-1%	-$8.4K	0.48%	45
2025 Q4	$616K	Sell	5,019 -93	-2%	-$11.3K	0.44%	47
2025 Q3	$567K	Buy	5,112 +22	+0.4%	+$2.5K	0.41%	51
2025 Q2	$564K	Sell	5,090 -234	-4%	-$24.9K	0.44%	47
2025 Q1	$597K	Sell	5,324 -194	-4%	-$20K	0.48%	37
2024 Q4	$510K	Sell	5,518 -435	-7%	-$39.2K	0.4%	46
2024 Q3	$499K	Sell	5,953 -40	-0.7%	-$3.05K	0.39%	48
2024 Q2	$411K	Sell	5,993 -29	-0.5%	-$1.94K	0.35%	61
2024 Q1	$441K	Sell	6,022 -464	-7%	-$35.7K	0.38%	59
2023 Q4	$525K	Buy	+6,486	New	+$505K	0.47%	56

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balanced Rock Investment Advisors's GILD Position: Q2 2026 in Review

Balanced Rock Investment Advisors increased its Gilead Sciences (GILD) stake by 0.63% in Q2 2026, buying an estimated $4.08K and bringing the position to 4,990 shares worth $630K. The position accounts for 0.39% of the portfolio, ranked #52.

Balanced Rock Investment Advisors first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $691K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Balanced Rock Investment Advisors held 4,990 shares of Gilead Sciences worth $630K as of Q2 2026.
Balanced Rock Investment Advisors bought 31 Gilead Sciences shares in Q2 2026, an estimated $4.08K.
Gilead Sciences made up 0.39% of Balanced Rock Investment Advisors's portfolio in Q2 2026, its #52 holding.
Balanced Rock Investment Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Balanced Rock Investment Advisors's Gilead Sciences position peaked at $691K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Balanced Rock Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.